Federation des caisses Desjardins du Quebec - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 20 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Federation des caisses Desjardins du Quebec ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$176,646
-1.6%
221,0000.0%0.00%0.0%
Q3 2022$179,443
+10.9%
221,0000.0%0.00%0.0%
Q2 2022$161,752
-14.0%
221,0000.0%0.00%0.0%
Q1 2022$188,092221,0000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Birch Grove Capital LP 9,000,000$7,529,0003.08%
Context Capital Management, LLC 16,700$13,919,0000.90%
Opti Capital Management, LP 11,460,000$9,548,0000.77%
DeepCurrents Investment Group LLC 22,500,000$18,593,0000.58%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 31,050,000$24,245,0000.56%
PenderFund Capital Management Ltd. 1,500,000$1,615,0000.40%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 25,000,000$20,932,0000.27%
AQR Arbitrage LLC 9,900,000$8,388,0000.22%
CSS LLC/IL 5,000,000$4,154,0000.15%
Verition Fund Management LLC 6,313,000$5,349,0000.06%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders